GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Quick Ratio

Dr Lalchandani Labs (BOM:541299) Quick Ratio : 1.85 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Dr Lalchandani Labs's quick ratio for the quarter that ended in Sep. 2023 was 1.85.

Dr Lalchandani Labs has a quick ratio of 1.85. It generally indicates good short-term financial strength.

The historical rank and industry rank for Dr Lalchandani Labs's Quick Ratio or its related term are showing as below:

BOM:541299' s Quick Ratio Range Over the Past 10 Years
Min: 1.38   Med: 2.48   Max: 4.83
Current: 1.85

During the past 11 years, Dr Lalchandani Labs's highest Quick Ratio was 4.83. The lowest was 1.38. And the median was 2.48.

BOM:541299's Quick Ratio is ranked worse than
51.07% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.9 vs BOM:541299: 1.85

Dr Lalchandani Labs Quick Ratio Historical Data

The historical data trend for Dr Lalchandani Labs's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Quick Ratio Chart

Dr Lalchandani Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.83 3.80 2.75 1.90 1.78

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.95 1.90 2.82 1.78 1.85

Competitive Comparison of Dr Lalchandani Labs's Quick Ratio

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Quick Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Quick Ratio falls into.



Dr Lalchandani Labs Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Dr Lalchandani Labs's Quick Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Quick Ratio (A: Mar. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(110.185-15.223)/53.201
=1.78

Dr Lalchandani Labs's Quick Ratio for the quarter that ended in Sep. 2023 is calculated as

Quick Ratio (Q: Sep. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(107.839-14.237)/50.642
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Dr Lalchandani Labs Quick Ratio Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines